P
PMV Pharmaceuticals D
D
PMVP
1.78000
USD
0.12
(7.23%)
Market Closed
Volume
27,542
EPS
0
Div Yield
0
P/E
-2
Market Cap
91,705,157
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: PMV Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.